Change of ownership at Vitanas and PFLEGEN & WOHNEN HAMBURG

Berlin/Hamburg, 14. August 2017 – The owners of Vitanas Holding GmbH (Vitanas) and PFLEGEN UND WOHNEN HAMBURG GmbH (PFLEGEN & WOHNEN HAMBURG) have successfully sold their majority shareholdings in the companies to funds, managed by Oaktree Capital Management, L.P. (“Oaktree”).

Vitanas and PFLEGEN UND WOHNEN HAMBURG are amongst the largest private nursing home operators in Germany with collectively 8,300 care beds. Vitanas was previously owned by the family of Nikolai P. Burkart (Burkart Verwaltung GmbH). PFLEGEN UND WOHNEN HAMBURG GmbH was equally owned by Andreas Franke Unternehmensgruppe and Vitanas.

equinet Bank AG and ACXIT Capital Partners have exclusively advised the sellers in this transaction. The parties agreed not to disclose any details of the transaction.

About Vitanas
Vitanas is one of the leading private healthcare operators in Germany. Among its key competencies are stationary and ambulant nursing care for seniors, geriatric care, care for mental illnesses i.e. mentally and in part physically disabled, and in-house training of personnel. As of May 2017, Vitanas employs approx. 4,400 people and offers a total capacity of 5,685 care beds.

About PFLEGEN & WOHNEN HAMBURG
PFLEGEN & WOHNEN HAMBURG is the largest stationary care provider in Hamburg. The organization offers stationary and short-term care for seniors, young adults and special care for dementia, awake coma, korsakoff syndrome, alcoholism and intercultural nursing care. As of May 2017, PFLEGEN & WOHNEN HAMBURG employs approx. 1,800 people and offers a total capacity of 2,691 care beds.

About Oaktree
Oaktree is a leader among global investment managers specializing in alternative investments, with $99 billion in assets under management as of June 30, 2017. The firm emphasizes an opportunistic, value-oriented and risk-controlled approach to investments in distressed debt, corporate debt (including high yield debt and senior loans), control investing, convertible securities, real estate and listed equities. Headquartered in Los Angeles, the firm has over 900 employees and offices in 18 cities worldwide. For additional information, please visit Oaktree’s website at http://www.oaktreecapital.com/.

About equinet
equinet Bank is an independent investment bank focused on small- and mid-caps and medium-sized companies. Since 1999, we have been offering individual solutions in all aspects of corporate finance, especially for small and medium-sized companies and family businesses – both private and listed. In addition to advising on the national and international M&A transactions, we also include succession situations, new stock emissions/IPOs and capital increases, as well as the structuring of bonds and Corporate Schuldschein loans, among our core competences. With our long-standing network, international partners and our excellent market and investor approach, we have successfully completed more than 100 M&A and capital market transactions over the past 5 years.

 

CONTACT

equinet Bank AG
Christoph Vigelius
Gräfstr. 97
60487 Frankfurt
Phone: +49 69 58997-0
E-Mail: christoph.vigelius@equinet-ag.de
www.equinet-ag.de

Entrepreneurial partnership between the Grönemeyer Institute and the MED 360° Group

Within the scope of the entrepreneurial partnership, the Grönemeyer Institute and the Med 360° Group strive to combine the interdisciplinary expertise and long-term experience of both companies in the sense of optimized treatment methods, new diagnostics and therapy centres under the sign of Grönemeyer Medizin® as well as a fast, near-home care of patients in NRW.

The Grönemeyer Medizin® Group was founded in 1997 by Prof. Dr. Grönemeyer and is the market leader in the field of ambulatory micro therapy. In the Grönemeyer Institutes in Bochum, Berlin and Hamburg, the expertise of diagnostics and treatment in the area of ​​back and joint pain is located. Prof. Dr. Grönemeyer relies on the interdisciplinary collaboration of different specialists and the method developed by him for micro therapy. A gentle diagnostics and miniaturized therapeutic interventions under tomographic control are used.

The Med 360° AG is a medical service provider with currently regional focus. In the practices of the Med 360°, approximately 600,000 patients – almost exclusively in the region of the Kassenärztlichen Vereinigung Nordrhein – are provided annually in outpatient and inpatient settings. This reflects a fifth of all patients radiologically and radiotherapeutically treated in this region. In total, approximately 1,300 employees provide diagnostic and therapeutic services in the fields of radiology, radiotherapy, nuclear medicine, neurology, oncology, orthopaedics, rheumatology, pneumology and physiotherapy, or are active in the related administrative areas. In 21 cities at present, the Group thus contributes significantly to the medical care of patients in the North Rhine region.

equinet Bank AG advised Prof. Dr. med. Dietrich Grönemeyer as shareholder of the Grönemeyer Institute and the Grönemeyer Institut, Bochum, exclusively in the preparation and implementation of the Transaction.

Successful Capital Increase by GESCO AG

GESCO AG, Wuppertal, successfully concluded a capital increase from the authorized capital without pre-emptive rights of the existing shareholders at March 21, 2017. The share capital has been increased from EUR 9,975,000.00 by EUR 864,499.00 to EUR 10,839,499.00 by issuing of 864,499 new shares with dividend entitlement as of 01 April 2016.

The new shares have been successfully placed at a price of EUR 23.50 per share to qualified investors in Germany and other European countries by way of an accelerated bookbuilding procedure.

Hence, the gross cash proceeds amount to approximately EUR 20.3 million. The net cash proceeds will be used to further strengthen GESCO AG’s equity following the acquisition of the Pickhardt & Gerlach Group, Finnentrop, which was finalized in January 2017, and broaden the platform for the further internal and external growth of the GESCO Group.

equinet Bank acted as Sole Lead Manager and Sole Bookrunner for this transaction.

 

Disclaimer

This publication is for information purposes only and is not intended, and should not be construed, as an offer to sell or a solicitation of an offer to buy or subscribe for any shares or other securities of GESCO AG, Wuppertal. No offer of securities is being, or will be, made in any jurisdiction.

This publication and the information contained herein is not for publication or distribution, directly or indirectly, in or into the United States, Canada, Australia or Japan.

The Securities of the Company described herein have not been and will not be registered under the US Securities Act of 1933, as amended (The “securities Act”), or the laws of any state, and may not offered or sold within the United States, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the securities act and applicable state laws. There will be no public offering of securities in the United States.

Takeover offer to the shareholders of Pfeiffer Vacuum Technology AG

Pangea GmbH, Maulburg, a fully owned subsidiary of Busch SE, Maulburg, announced on January 24, 2017 its intent to offer the shareholders of Pfeiffer Vacuum Technology AG a cash amount of €96,20 per share for the shares they hold by way of a voluntary public takeover (cash offer) according to the German Securities and Takeover Act. When the cash offer was announced, the bidder held shares representing 29.98% of the issued share capital of Pfeiffer Vacuum Technology AG. The offer has a total volume of approx. € 665m.The corresponding offer document was published on February 13, 2017.

According to the German Securities and Takeover Act, the Management Board and the Supervisory Board of Pfeiffer Vacuum Technology AG issued a reasoned opinion on the takeover bid.

In the context of this reasoned opinion, equinet Bank AG provided a fairness opinion addressed to the Management Board and Supervisory Board of Pfeiffer Vacuum Technology AG.

equinet Bank AG strengthens its position as an expert in the German small and midcap segment

equinet Bank AG is further expanding its team by adding a total of four new employees in key areas of its business. The bank is thus setting the course for its further development after a number of high-caliber specialists and managers have already been hired over the past quarters. As of April 1, 2017, Michael Schneiders, Patrick Bartter and Christopher Seedorf will strengthen the areas of Sales and Sales Trading and Stefan Augustin will be joining the research team. All of the new employees are joining equinet from Oddo Seydler Bank.

Lutz Weiler, CEO of equinet Bank AG, comments as follows: “We are convinced that our new colleagues, with their many years of experience in the banking business, their expertise and their international networks, will help us to successfully develop our services in the interests of our customers in all fields of activity. Their impressive track records in the currently challenging market environment have already proven their competence.” Not only our customers in the fields of activity of Equity and Debt, but also in the primary and secondary market business will benefit from our new additions, allowing us to achieve increased quality and efficiency along the entire value chain. The Management Board expects to see significant positive effects on the sales and results side as a result of these moves.

“Given the emerging market transformation in connection with MiFID 2, we are emphasizing our high commitment in the small and mid-cap segment by adding to our staff. We see these changes as an opportunity for our company. We want to be a specialized provider for German SMEs and further strengthen our position as a credible and competent partner into the future as well. As a German member of the European Securities Network, we enable our customers to benefit from our exclusive access to local investors and analysts across Europe,” Weiler adds.

 

The new additions to equinet Bank AG at a glance

  • Michael Schneiders has specialized in German equity products over the last 20 years as a sales expert and in management. He has always served as an interface between sales and corporate finance, overseeing a large number of successful capital market transactions. At Oddo Seydler, he recently helped reshape German brokerage activities into a dual-country broker. Prior to that, he directed the sales desk at Sal. Oppenheim as Co-Head for Germany, leading the activities of Cheuvreux and Kepler Cheuvreux in Australia and Great Britain.
  • Over the last 20 years, Patrick Bartter has been responsible for various German and European banks as a Sales Trader for both German and Pan-European equity products in the secondary market. He brings extensive experience both in technical processing of equity deals and in systemic front-end structuring. For the past ten years, Patrick Bartter has been active as a “hybrid” Sales Trader – a salesperson who also trades.
  • Christopher Seedorf worked for Oddo Seydler’s sales team for over three years. During this time, he built up the broker’s business in the German-speaking region of Switzerland and in Scandinavia. His client focus is on hedge funds in Switzerland and “Long Only Small and Mid Cap Funds” in Helsinki, Stockholm and Copenhagen.
  • Over the past 20 years, Stefan Augustin has been able to gain valuable experience in asset management as well as the buy- and sell-side at various German and European banks, establishing a large investor network in Europe. For more than a decade, he has been analyzing German small and midcaps in the mechanical engineering sector, participating for instance in the IPOs of Kion and Stabilus. Stefan Augustin particularly specializes in the conceptual design of research products.

 

New setup in the Markets Division

These personnel changes also have an impact on the internal corporate structure of equinet Bank AG. For instance, the bank plans to assign its work more strongly to individual persons responsible. Michael Schneiders, who also serves as Head of Sales, will be responsible for Equities and Research. Tim Schuldt’s role as Head of Research will remain unaffected by this move, as with Kai Winkelmann’s function as General Manager and Head of Trading.

 

About equinet Bank AG

equinet Bank AG, headquartered in Frankfurt /Main, was founded in 1999 and sees itself as an “entrepreneur among bankers.” It is primarily responsible for medium-sized companies in financing and capital market questions and offers trading and sales services, as well as research products. Around 90 experienced investment bankers, securities traders, analysts and sales professionals develop and implement individual solutions.

 

Contact:
equinet Bank AG
Gräfstr. 97
60487 Frankfurt
Phone: +49 69 58997-0
email: info@equinet-ag.de
www.equinet-ag.de

 

Press contact:
cometis AG
Henryk Deter / Thorben Burbach
Phone: +49 611 20 58 55-23
Fax: +49 611 20 58 55-66
email: burbach@cometis.de
www.cometis.de

Sucessful Bondplacement of arsago Wohnen Holding I GmbH, Pöcking/München

equinet Bank successfully placed a 45 Mio. EUR Bond of the arsago Wohnen Holding I GmbH, Pöcking/München. The notes were offered exclusively to institutional investors in a private placement.

The notes will be redeemed at their principal amount in December 2023.

To protect the bondholders a trustee has been appointed to, amongst others, insure the provision of collateral. Among the collateral is a mortgage.

The net proceeds from the issue will be used to purchase a residential real estate portfolio in several cities in Germany.

The Frankfurt-based investment bank equinet Bank AG acted as Sole Lead Manager and Sole Bookrunner for this transaction.

 

Disclaimer

This publication constitutes neither an offer to sell nor an invitation to buy securities. The bond of arsago Wohnen Holding I GmbH (the “Bonds”) may not be offered or sold in the United States or to or for the account or benefit of “U.S. persons” (as such term is defined in Regulation S under the U.S. Securities Act of 1933, as amended (the “Securities Act”)). The Bonds have already been sold.

Sucessful Bondplacement of CG Frankfurt Ostend GmbH & Co KG, Berlin

equinet Bank successfully placed end of December 2016 a 64 Mio. EUR Bond of the CG Frankfurt Ostend GmbH & Co KG, Berlin, a subsidiary of CG Gruppe AG. The notes were offered exclusively to institutional investors in a private placement.

The notes will be redeemed at their principal amount in June 2022.

To protect the bondholders a trustee has been appointed to, amongst others, insure the provision of collateral. Among the collateral is a mortgage. The notes are awarded with the rating note of BBB- (Investment Grade).

The net proceeds from the issue will be used to purchase the East End site in Frankfurt am Main (between Henschelstrasse, Ostparkstrasse and Danziger Platz).

The Frankfurt-based investment bank equinet Bank AG acted as Sole Lead Manager and Sole Bookrunner for this transaction.

Disclaimer

This publication constitutes neither an offer to sell nor an invitation to buy securities. The bond of CG Frankfurt Ostend GmbH & Co KG (the “Bonds”) may not be offered or sold in the United States or to or for the account or benefit of “U.S. persons” (as such term is defined in Regulation S under the U.S. Securities Act of 1933, as amended (the “Securities Act”)). The Bonds have already been sold.

Corporate Schuldschein Loan for Expotechnik International Holding GmbH & Co. KG

equinet Bank AG successfully arranged a Corporate Schuldschein Loan for Expotechnik International Holding GmbH & Co. KG (Expotechnik). German and foreign institutional investors from the commercial banks sector as well as the federal state banks sector subscribed to the Borrower’s note loans.

The Corporate Schuldschein Loan is part of the newly structured financing of Expotechnik. Moreover, equinet Bank has arranged additional working capital credit lines for the client. Equipped with the new financial structure in the total amount of more than EUR 20m, Expotechnik is ideally prepared to realise its growth strategy over the next years.

The family-owned company Expotechnik is a leading service provider for brand presentations with an experience of more than 45 years. Main activities of Expotechnik are “Exhibitions”, “Events” and “Environments” – national and international trade shows, events, lounges & showrooms, exhibition spaces, office room. Expotechnik is globally active with offices in more than 14 locations in Europe, Asia-Pacific and North America. The company implements 2,000 projects every year with exhibition areas of 12 to 12,000 square meters. Expotechnik’s clients include leading international concerns such as Audi, Deutsche Lufthansa, Frauenhofer and Nestle. Additionally, Expotechnik serves small and medium-sized enterprises such as Krones, Phoenix Contact or Sew-Eurodrive as well. In 2015 Expotechnik generated revenues of more than EUR 60m.

equinet Bank AG acted as Sole Lead Arranger in this transaction.

Hörmann Finance EUR 30m corporate bond successfully placed

equinet Bank acting as Joint Lead Manager and Joint Bookrunner succesfully launched a EUR 30m corporate bond (DE000A2AAZG8) of Hörmann Finance GmbH. The notes have met very strong interest from institutional and private investors as well and the subscription was closed on the first day of subscription. The notes will be redeemed at their principal amount in November 2021 and will bear interest at a rate of 4.50% per annum payable annually.

The coupon was fixed at the middle of the range of 4.25% to 4.75% in a bookbuilding  with institutional investors. The notes are included for trading at the Open Market segment of Deutsche Börse (Entry Standard).

The net proceeds from the issue will serve the redemption of the outstanding EUR 50m corporate bond 2013/2018 (WKN A1YCRD), which will be premature terminated. For total repayment, further cash will be used and therefore financial liabilities will be in total reduced.

The technology specialist Hörmann Finance GmbH has established itself since the issue of the listed corporate bond in 2013 as a reliable capital market partner and solid investment. In the business year 2015 Hörmann Finance GmbH with an average payroll of approx. 2,300 posted total sales of around EUR 435m, the EBIT amounted to EUR 11.9m and the net result to EUR 6.2m. As of June 30, 2016, with cash and cash equivalents of EUR 71m the company was debt-free and had an equity ratio of 33%. In view of the solid capital structure and financial flexibility Euler Hermes Rating GmbH increased its Rating of Hörmann Finance GmbH in October 2016 from BB- to BB (stable outlook).

Disclaimer
This publication constitutes neither an offer to sell nor an invitation to buy securities. The bond of Hörmann Finance GmbH (the “Bonds”) may not be offered or sold in the United States or to or for the account or benefit of “U.S. persons” (as such term is defined in Regulation S under the U.S. Securities Act of 1933, as amended (the “Securities Act”)). The Bonds have already been sold.

equinet Bank AG successfully arranged a Schuldschein loan (Borrower’s note loans) for SANOCHEMIA Pharmazeutika AG

equinet Bank successfully arranged a Schuldschein loan for SANOCHEMIA. Three Austrian banks subscribed to the Borrower’s note loans.

The secured Schuldschein loan together with a bilateral loan serves the refinancing of the SANOCHEMIA’s corporate bond 2012/17 in the amount of EUR 10 Mio.

The listed SANOCHEMIA Pharmazeutika AG is an international operating full integrated pharmaceutical company with long experience in the development and production of active pharmaceutical ingredients, drugs and diagnostics. SANOCHEMIA’s business operations are human pharmaceuticals, veterinary pharmaceuticals, production (i.e. on a contract manufacturing basis) as well as research and development. The Company focuses on the areas oncology, pain management, neurodegeneration as well as diagnostics based on contrast media. In fiscal year 2014/15 SANOCHEMIA generated total revenues of EUR 35,6m and an EBITDA of EUR 4,2m.

equinet Bank AG acted as Sole Lead Arranger in this transaction.

Disclaimer

This publication constitutes neither an offer to sell nor an invitation to buy securities. The Borrower’s note loans of SANOCHEMIA Pharmazeutika AG (the “Note”) may not be offered or sold in the United States or to or for the account or benefit of “U.S. persons” (as such term is defined in Regulation S under the U.S. Securities Act of 1933, as amended (the “Securities Act”)). The Note has already been sold.